Clinical Trial Update: A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) Malaria [Phase 2]

View source ↗

Summary

Phase 2 pediatric pharmacokinetics, safety, and efficacy study of tafenoquine for Plasmodium vivax malaria has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Vivax Malaria

Drugs mentioned

• Tafenoquine (tafenoquine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria, Vivax | Phase 2 | Status: COMPLETED | Results posted: 2020-11-02